Cryo-Cell Receives NYSE American Continued Listing Notice

OLDSMAR, Fla.–(BUSINESS WIRE)–Cryo-Cell International, Inc. (NYSE American LLC: CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced that is has received a written notice (the “Notice”) from the NYSE American LLC (the “NYSE American”) stating that the Company is not in compliance with certain continued … [Read more…]

Virta Health’s Nutrition Therapy Extends Survival by 34% in Stage IV Pancreatic Cancer Patients, New Clinical Trial Shows

Virta’s nutritional intervention shown to improve survival outcomes in randomized, controlled Phase II clinical trial on patients with one of the deadliest cancers DENVER–(BUSINESS WIRE)–Virta Health, the leader in reversing metabolic disease, announced today results from a randomized, controlled Phase II clinical trial (RCT), offering an early signal that could reshape how advanced pancreatic cancer … [Read more…]

Serenity Mental Health Centers Offers Psychiatric Care for Depression in Dallas

Dallas residents can access faster, convenient treatment for depression DALLAS–(BUSINESS WIRE)–Serenity Mental Health Centers, a leader in innovative psychiatric care and one of the fastest-growing mental health providers in the nation, today announced the expansion of its depression treatment in its clinics in Frisco, Las Colinas, Fort Worth, Southlake, Arlington, and University Park. Serenity’s board-certified … [Read more…]

o9 Announces Teleflex™ Global Go-Live for Integrated Demand and Supply Planning

DALLAS–(BUSINESS WIRE)–o9, a leading enterprise AI software platform provider for transforming planning and decision-making, today announced that Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, is now live globally with Demand Planning and Supply Planning on the o9 platform. This deployment supports Teleflex’s multi-year effort to enhance its end-to-end integrated business planning … [Read more…]

MindMaze Therapeutics Appoints HealthTech Veteran Zach Henderson as CEO to Accelerate Global Commercial Scale

Former Rune Labs and Glooko executive to lead MindMaze’s next phase of growth, focusing on U.S. market expansion and the delivery of scalable, AI-driven neurorestorative care. GENEVA–(BUSINESS WIRE)–MindMaze Therapeutics Holding SA (SIX: MMTX) (MindMaze Therapeutics, or the Company), a global leader in brain technology and precision neurotherapeutics, today announced the appointment of Zach Henderson as … [Read more…]

Meiji Seika Pharma Initiates Phase I Clinical Trial in Australia Evaluating ME3241, an Anti-PD-1 Agonist Antibody Discovered Through Collaborative Research With FBRI

TOKYO–(BUSINESS WIRE)–Meiji Seika Pharma Co., Ltd. (Headquarters: Chuo-ku, Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) announced today that it has initiated a Phase I clinical trial of ME3241 (development code), an anti-PD-1 agonist monoclonal antibody discovered through collaborative research with the Foundation for Biomedical Research and Innovation at Kobe (Headquarters: Kobe, Japan; President: Shuh … [Read more…]

United Therapeutics Corporation Announces Full Results of TETON-2 Phase 3 Clinical Trial Published in The New England Journal of Medicine

The pivotal study of Tyvaso® (treprostinil) Inhalation Solution demonstrated a statistically significant preservation of lung function across all subgroups, as measured by absolute forced vital capacity (FVC), and fewer clinical worsening events, compared with placebo over 52 weeks in patients with idiopathic pulmonary fibrosis (IPF) Study authors noted TETON-2 is the first study to show … [Read more…]

Landmark Study Shows Average Cost Savings of $80,000 Per Child and Overall Improved Health Outcomes Following GeneDx Exome and Genome Testing

New data shows up to 61% reduction in healthcare costs for children with neurodevelopmental disorders in the 12 months following ExomeDx™ and GenomeDx™ testing, regardless of the test result GAITHERSBURG, Md.–(BUSINESS WIRE)–GeneDx (Nasdaq: WGS), the leader in rare disease diagnosis and improving health through the power of genomic data, today announced findings from the Genetic … [Read more…]

HIMSS Survey: 60% of Health Systems Can’t Protect Unmanaged Medical Devices

Leaders rank avoiding clinical downtime as their top microsegmentation priority, yet 40% say fear of disruption blocks adoption SAN JOSE, Calif.–(BUSINESS WIRE)–#HIMSS2026—Elisity, the pioneer in identity-based microsegmentation, today announced the release of The Implementation Paradox: Healthcare Leaders Want Microsegmentation-Level Security Without Disruption, a comprehensive report co-published with Healthcare Information and Management Systems Society (HIMSS) Market … [Read more…]

Codoxo Launches Deepfake Detection to Stop AI-Generated Medical Fraud Before Payment

Tool helps payers identify synthetic or manipulated medical documentation and images earlier, strengthening fraud prevention and protecting provider trust DULUTH, Ga.–(BUSINESS WIRE)–Codoxo, the leading provider of AI and generative AI-powered healthcare payment integrity solutions, today announced the launch of Deepfake Detection, an AI-driven fraud detection tool now being deployed with health plans across the U.S. … [Read more…]